Differential expression of the embryo/cancer gene ECS A (DPPA 2), the cancer/testis gene BORIS and the pluripotency structural gene OCT 4, in human preimplantation development

Molecular Human Reproduction

Volumn 14, Issue 6, 2008, Pages 347-355

  Monk, Marilyn ^a   Hitchins, Megan ^a,b   Hawes, Susan ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

BORIS; ECSA(DPPA2); Human embryo; Human ES cells; OCT4

Indexed keywords

BROTHER OF THE REGULATOR OF IMPRINTED SITES PROTEIN; EMBRYO CANCER SEQUENCE A PROTEIN; GENE PRODUCT; OCTAMER TRANSCRIPTION FACTOR 4;

ARTICLE; BLASTOCYST; CELL CULTURE; CELL FUNCTION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO CELL; EMBRYO DEVELOPMENT; GAMETOGENESIS; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INNER CELL MASS; NUCLEOTIDE SEQUENCE; OOCYTE; PREIMPLANTATION EMBRYO; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PROTEIN BINDING; PSEUDOGENE; STEM CELL;

BASE SEQUENCE; CELLS, CULTURED; CLEAVAGE STAGE, OVUM; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASMS; NUCLEAR PROTEINS; OCTAMER TRANSCRIPTION FACTOR-3; OOCYTES; PLURIPOTENT STEM CELLS; SEQUENCE HOMOLOGY, NUCLEIC ACID; TESTIS;

EID: 45749106725     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gan025     Document Type: Article

References (71)

1. Abdel-Rahman B, Fiddler M, Rappolee D, Pergament E. Expression of transcription regulating genes in human preimplantation embryos. Hum Reprod 1995;10:2787-2792.
2. Adjaye J, Bolton V, Monk M. Developmental expression of specific genes detected in high-quality cDNA libraries from single human embryos. Gene 1999;237:373-383.
3. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000;227:271-278.
4. Aravind L, Koonin EV. SAP - a putative DNA-binding motif involved in chromosomal organisation. Trends Biochem Sci 2000;25:112-114.
5. Baker DEC, Harrison NJ, Maltby E, Smith K, Moore HD, Shaw PJ, Heath PR, Holden H, Andrews PW. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 2007;25 207-215.
6. Bortvin A, Eggan K, Skaletsky H, Akutsu H, Berry DL, Yanagimachi R, Page DC, Jaenisch R. Incomplete reactivation of OCT4-related genes in mouse embryos cloned from somatic nuclei. Development 2003;130 8): 1673-1680.
7. Cantz T, Key G, Bleidissel M, Gentile L, Han DW, Brenne A, Schöler HR. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 2008;26:692-697.
8. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. Functional expression cloning of Nanog, a pluripotency gene sustaining factor in embryonic stem cells. Cell 2003;113:643-655.
9. De Plaen E, De Backer O, Arnaud D, Bonjean B, Chomez P, Martelange V, Avner P, Baldacci P, Babinet C, Hwang SY et al. A new family of mouse genes homologous to the human MAGE genes. Genomics 1999; 55: 176-184.
10. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 1996;93: 7149-7153.
11. Evans M, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature (Lond) 1981;292:154-155.
12. Ezeh UI, Turek PJ, Reijo RA, Clark AT. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 2005;104:2255-2265.
13. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich, M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 1988;48:1159-1161.
14. Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y, Cedar H, Bergman Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 2006;8:188-194.
15. Fulka H, Mrazek M, Tepla O, Fulka J, Jr. DNA methylation pattern in human zygotes and developing embryos. Reproduction 2004;128 703-708.
16. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 1983;11:6883-6894.
17. Gidekel S, Bergman Y. A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J Biol Chem 2002;277:34521-34530.
18. Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 2003;4:361-370.
19. Goelz SE, Vogelstein BM, Hamilton SP, Feinberg AP. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985;228:187-190.
20. Goto T, Adjaye JA, Rodeck C, Monk M. Identification of genes expressed in human primordial germ cells at the time of entry of the female germ line into meiosis. Mol Mum Reprod 1999;5:851-860.
21. Goto T, Jones GM, Lolatgis N, Pera M, Trounson AO, Monk M. Identification and characterisation of known and novel transcripts expressed during the final stages of human oocyte maturation. Mol Reprod Dev 2002;62: 13-28.
22. Grant M, Zuccotti M, Monk M. Methylation of CpG sites of two X-linked genes coincides with X-inactivation in the female mouse embryos but not in the germ line. Nat Genet 1992;2:161-166.
23. Hajkova P, Erhardt S, Lane N, Haaf T, El-Maarri O, Reik W, Walter J, Surani MA. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 2002;117:15-23.
24. Hansis C, Grifo JA, Krey LC. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod 2000;6 11): 999-1004.
25. Hart AH, Hartley L, Ibrahim M, Robb L. Identification, cloning and expression analysis of the pluripotency promoting nanog genes in mouse and human. Dev Dynamics 2004;230:187-198.
26. Hay D, Sutherland L, Clark J. Oct4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 2004;22:225-235.
27. Hochedlinger K, Yasuhiro Y, Beard C, Jaenisch R. Ectopic expression of OCT4 blocks progenitor-cell differentiation and causes dyslasia in epithelial tissues. Cell 2007;121:465-477.
28. Hoffmann MJ, Muller M, Engers R, Schulz WA. Epigenetic control of CTCFL/ BORIS and OCT4 expression in urogenital malignancies. Biochem Pharmacol 2006;72:1577-1588.
29. Holding C, Bolton V, Monk M. Detection of human novel developmental genes in cDNA derived from replicate individual preimplantation embryos. Mol Hum Reprod 2000;6:801-809.
30. Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, Fischette MR, Adnani MT, Loukinov DI, Vatolin S, Risinger JI et al. Reciprocal binding of CTFC and BORIS to the NY-ESO-1 promoter coincides with depression of this cancer-testis gene in lung cancer cells. Cancer Res 2005; 65:7751-7762.
31. Hyslop L, Stojkovic M, Armstrong L, Walter T, Stojkovic P, Przyborski S, Herbert M, Murdoch A, Strachan T, Lako M. Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 2005;23:1035-1043.
32. Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C, Schafer X, Lun Y, Lemischka IR. Dissecting self-renewal in stem cells with RNA interference. Nature 2006;442:533-538.
33. Jin T, Branch DR, Zhang X, Qi S, Youngson B, Goss PE. Examination of POU homeobox gene expression in human breast cancer cells. Int J Cancer 1999;81:104-112.
34. John T, Caballero OL, Svobodová SJ, Kong A, Chua R, Browning J, Fortunato S, Gedye CA, Davis ID, Altorki N et al. ECSA/DPPA2 is an embryo-cancer antigen that is co-expressed with cancer-testis antigens in Non-Small-Cell Lung Cancer. Clin Canc Res 2008;14 3291-3298.
35. Kafri T, Ariel M, Brandeis M, Shemer R, Urven L, McCarrey J, Cedar H, Razin A. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev 1992;6:705-714.
36. Klenova EM, Morse HC, III, Ohlsson R, Lobanenkov VV. The novel BORIS+CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Cancer Biol 2002;12:399-414.
37. Koslowski M, Bell C, Seitz G, Lehr HA, Roemer K, Müntefering H, Huber C, Sahin U, Türeci O. Frequent nonrandom activation of germ-line genes in human cancer. Cancer Res 2004;64:5988-5993.
38. Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC Gilliland DG, Golub TR et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006;442:754-755.
39. Lehmann MH, Weber J, Gastmann O, Sigush HH. Pseudogene-free amplification of human GAPDH cDNA. Biotechniques 2002;33 766-770.
40. Lengner CJ, Camargo FD, Hochedlinger K, Welstead GG, Zaidi S, Gokhale S, Scholer HR, Tomilin A, Jaenisch R. Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 2007;1 403-415.
41. Liedtke S, Enczmann J, Waclawcyzk S, Wernet P, Kogler G. Oct4 an its pseudognes confuse stem cell research. Cell Stem Cell 2007;4 364-366.
42. Looijenga LH, Stoop H, de Leeuw UP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003;63:2244-2250.
43. Loriot A, Sterpin C, De Backer O, De Smet C. Mouse embryonic stem cells induce targeted DNA demethylation within human MAGE-A1 transgenes. Epigenetics 2008;3:38-42.
44. Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chemukhin I, Mannan P, Larsson E, Kanduri C, Vostrov AA et al. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc Natl Acad Sci USA 2002;99:6806-6811.
45. Maldonado-Saldivia J, van den Bergen J, Krouskos M, Gilchrist M, Sinclair AH, Surani A, Western PS. Dppa2 and Dppa4 are closely linked SAP motif genes restricted to pluripotent cells and the germ line. Stem Cells Express 2006;25:19-28.
46. Matin MM, Walsh JR, Gokhale PJ. Specific knockdown of Oct4 and β2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 2004;22 659-668.
47. Matsui Y, Zsebo K, Hogan BLM. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 1992;70: 841-847.
48. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003;113:631-642.
49. Monk M. A stem line model for cellular and chromosomal differentiation in early mouse development. Differentiation 1981;19:71-76.
50. Monk M. Changes in DNA methylation during mouse embryonic development in relation to X-chromosome activity and imprinting. In: Holliday R, Monk M, Pugh J (eds). DNA Methylation and Gene Regulation. Vol. 326, Phil Trans R Soc. Lond, 1990. 299-312. b326.
51. Monk M, Holding C. Human embryonic genes expressed in cancer cells. Oncogene 2001;2:8085-8091.
52. Monk M, McLaren A. Random X-chromosome inactivation in female primordial germ cells in the mouse. J Embryo exp Morph 1981;63:75-84.
53. Monk M, Boubelik M, Lehnert S. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 1987;99:371-382.
54. Niwa H, Miyazaki J, Smith A. Quantitative expression of Oct3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature 2000;24:372-376.
55. Ohlsson R, Renkawitz R, Lobabebkov V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet 2001;17:520-527.
56. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad WC, Daniel VC, Yu W, Berman DM et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007;39:237-242.
57. Old LJ. Cancer/testis antigens - a new link between gametogenesis and cancer. Cancer Immun 2001;1:1-7.
58. Renaud S, Pugacheva EM, Delgardo MD, Braunschweig R, Abdullaev Z, Loukinov D, Benhattar J, Lonanenkov V. Expression of the CTCF-paralogous cancer-testis gene,, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors. Nucl Acids Res 2007;35:7372-7388.
59. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat Biotechnol 2000;18:399-404.
60. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, Staudt LM. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990;345:686-692.
61. Salpekar A, Huntriss J, Bolton V, Monk M. The use of amplified cDNA to monitor the expression profiles of seven imprinted genes in human oocytes and preimplantation embryos. Mol Hum Reprod 2001;7 101-106.
62. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: An expanding family of targets for cancer immunotherapy. Immunol Rev 2002;188:22-32.
63. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007;39 232-236.
64. Scholer HR, Hatzopoulos AK, Balling R, Suzuki N, Gruss P. A family of octamer-specific proteins present during mouse embryogenesis: Evidence for germline-specific expression of an Oct factor. EMBO J 1989; 8:2543-2550.
65. Suo G, Han J, Wang X et al. Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 2005;337:1047-1051.
66. Szabó PE, Hübner K, Schöler H, Mann JR. Allele-specific expression of imprinted genes in mouse migratory primordial germ cells. Mech Dev 2002;115:157-160.
67. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE. Oct4 expression in adult human stem cells: Evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005;26 495-502.
68. Takeda J, Susumu S, Bell GI. Human Oct3 gene family: CDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucl Acids Res 1992; 20: 4613-4620.
69. Vatolin S, Abdullaev Z, Pack SD, Flanagan PT, Custer M, Loukinov DI, Pugacheva E, Hong JA, Morse H, 3rd, Schrump, DS et al. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Res 2005; 65 7751-7762.
70. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, Weisenberger DJ, Campan M, Young J, Jacobs I et al. Epigenetic stem cell signature in cancer. Nat Genet 2007;39:157-158.
71. Yan HHN, Cheng CY. Blood barrier dynamics are regulated by an engagement/ disengagement mechanism between tight and adherens junctions via peripheral adaptors. Proc Natl Acad Sci 2005;102:11722-11727.